|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating costs and expenses: | |||||
| Inventor royalties, contingent legal fees, litigation and licensing expenses | |||||
| Research and development expenses (including non-cash stock-based compensation expenses of $1,560 and $1,859, respectively) | |||||
| General and administrative expenses (including non-cash stock-based compensation expenses of $2,250 and $2,923, respectively) | |||||
| Total operating costs and expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Net loss | |||||
| Less: Net loss attributable to noncontrolling interest | |||||
| Net loss attributable to common shareholders | |||||
| Net loss per share: | |||||
| Basic | |||||
| Diluted | |||||
| Basic | |||||
| Diluted | |||||
Loading...